menu search

AMLX / Could Amylyx Pharmaceuticals Have a Blockbuster ALS Treatment?

Could Amylyx Pharmaceuticals Have a Blockbuster ALS Treatment?
The FDA's currently looking at an application for the company's lead candidate. Read More
Posted: Mar 29 2022, 05:45
Author Name: The Motley Fool
Views: 103155

AMLX News  

Amylyx Pharmaceuticals's ALS dug rejected again by EU regulators

By Proactive Investors
October 13, 2023

Amylyx Pharmaceuticals's ALS dug rejected again by EU regulators

Amylyx Pharmaceuticals shares fell Friday after its ALS (amyotrophic lateral sclerosis) drug was denied marketing authorization by European Union regu more_horizontal

Amylyx Pharmaceuticals shares fall after ALS treatment is rejected by European regulator

By Market Watch
October 13, 2023

Amylyx Pharmaceuticals shares fall after ALS treatment is rejected by European regulator

Amylyx Pharmaceuticals Inc. AMLX, -4.60% shares fell 7.5% premarket on Friday after the company said the European Medicines Agency had confirmed its n more_horizontal

EU regulator declines to recommend Amylyx' ALS drug

By Reuters
October 13, 2023

EU regulator declines to recommend Amylyx' ALS drug

Amylyx Pharmaceuticals said on Friday the European Union medicines regulator for the second time declined to recommend a marketing authorisation for t more_horizontal

Amylyx Pharmaceuticals, Inc. (AMLX) Surpasses Q2 Earnings and Revenue Estimates

By Zacks Investment Research
August 10, 2023

Amylyx Pharmaceuticals, Inc. (AMLX) Surpasses Q2 Earnings and Revenue Estimates

Amylyx Pharmaceuticals, Inc. (AMLX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.01 per share. This more_horizontal

3 Biotech Stocks to Buy Before Drug Trials End

By InvestorPlace
July 28, 2023

3 Biotech Stocks to Buy Before Drug Trials End

Clinical trials can be like a tightrope over a minefield for biotech investors. Only a fraction of drugs even succeed through clinical trials to recei more_horizontal

Why Shares of Amylyx Pharmaceuticals Were Up Monday

By The Motley Fool
July 24, 2023

Why Shares of Amylyx Pharmaceuticals Were Up Monday

Amylyx focuses on neurodegenerative diseases. After launching its first product in September, the company turned its first profitable quarter. more_horizontal

Amylyx (AMLX) Down on Negative CHMP Opinion for ALS candidate

By Zacks Investment Research
June 26, 2023

Amylyx (AMLX) Down on Negative CHMP Opinion for ALS candidate

Amylyx's (AMLX) shares plunge on getting a negative opinion from the Committee for Medicinal Products for Human Use for the marketing authorization of more_horizontal

Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?

By The Motley Fool
June 13, 2023

Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?

Amylyx Pharmaceuticals and Viking Therapeutics have been on fire over the past year. Even so, both companies still look incredibly undervalued relativ more_horizontal


Search within

Pages Search Results: